688136.SH
科兴制药
SSE · Healthcare · Biotechnology · CN
CNY 23.60
+14.84%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- 32.81x
- P/E 2027E
- 24.21x
- P/E 2028E
- 18.16x
- P/S forward
- 12.43x
Trailing multiples
Trailing twelve months
- P/E TTM
- 30.64x
- PEG TTM
- —
- Price / book
- 2.59x
- Price / sales
- 2.81x
- Price / cash flow
- 60.86x
Enterprise value
- Enterprise value
- CNY 4.4B
- EV / sales
- 2.99x
- EV / EBITDA
- 16.04x
- EV / EBIT
- 40.31x
- Market cap
- CNY 4.8B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Mar 1, 2026